EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Varicella Zoster Virus and Stroke: An Intricate Relationship

Achilleas Livieratos, Lars Erik Schiro, Charalambos Gogos, Georgios Ntaios iD, Karolina Akinosoglou iD

Viruses · 08.12.2025 · 17 (12) · 1591

DOI: 10.3390/v17121591 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 08.12.2025. Verfasst von Achilleas Livieratos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, 15238 Athens, Greece. Hauptthemen laut MEDLINE: Stroke, Herpesvirus 3, Human, Herpes Zoster, Varicella Zoster Virus Infection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Varicella Zoster Virus (VZV), responsible for chickenpox and herpes zoster, has emerged as a significant contributor to cerebrovascular disease. Mounting evidence indicates that VZV reactivation may precipitate ischemic and hemorrhagic stroke through mechanisms of viral vasculopathy, immune evasion, and vascular inflammation. While antiviral therapy remains the cornerstone of treatment, several adjunctive regimens exhibit encouraging results in controlling endothelial inflammatory response. This targeted review synthesized findings from 31 studies, including clinical cohorts, in vitro models, and pathological analyses, to evaluate the relationship between VZV and stroke, with emphasis on treatment management beyond antivirals. Evidence demonstrates that VZV antigens are frequently detected within cerebral arteries, where they induce transmural inflammation, endothelial dysfunction, and thrombosis, thereby increasing stroke risk, particularly in the weeks following herpes zoster. Adjunctive therapies such as corticosteroids, statins, and resveratrol show promise in mitigating vascular inflammation, though clinical validation is limited. Preventive measures, especially zoster vaccination, significantly reduce herpes zoster incidence and may lower subsequent stroke risk, yet global uptake remains insufficient. Collectively, the data underscore the need for improved diagnostic tools, combination treatment strategies, and expanded vaccination programs to address the substantial public health burden of VZV-associated stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeHerpesvirus 3, HumanHerpes ZosterVaricella Zoster Virus InfectionHumansAntiviral AgentsChickenpoxAnimals

Stichwörter der Autor:innen

Varicella Zoster Virusstrokevasculopathy

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Independent Researcher, 15238 Athens, Greece.
  • Independent Researcher, 0284 Oslo, Norway.
  • Department of Medicine, University of Patras, 26504 Rio, Greece.
  • 1st Medical Propedeutic Department of Internal Medicine & Stroke Unit, AHEPA Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Rio, Greece.

ORCID-Profile: Georgios Ntaios, Karolina Akinosoglou

Zitieren

APA

Livieratos, A., Schiro, L. E., Gogos, C., Ntaios, G., & Akinosoglou, K. (2025). Varicella Zoster Virus and Stroke: An Intricate Relationship. Viruses, 17(12), 1591. https://doi.org/10.3390/v17121591

Vancouver

Livieratos A, Schiro LE, Gogos C, Ntaios G, Akinosoglou K. Varicella Zoster Virus and Stroke: An Intricate Relationship. Viruses. 2025;17(12):1591. doi:10.3390/v17121591

BibTeX
@article{Livieratos2025,
  author = {Livieratos, Achilleas and Schiro, Lars Erik and Gogos, Charalambos and Ntaios, Georgios and Akinosoglou, Karolina},
  title = {Varicella Zoster Virus and Stroke: An Intricate Relationship},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {12},
  pages = {1591},
  doi = {10.3390/v17121591}
}
Kostenlos starten →